162 related articles for article (PubMed ID: 38671413)
41. Clinicopathologic significance of ROCK2 expression in oral squamous cell carcinomas.
Dourado MR; de Oliveira CE; Sawazaki-Calone I; Sundquist E; Coletta RD; Salo T
J Oral Pathol Med; 2018 Feb; 47(2):121-127. PubMed ID: 29052912
[TBL] [Abstract][Full Text] [Related]
42. High HMGA2 Expression Correlates with Reduced Recurrence-free Survival and Poor Overall Survival in Oral Squamous Cell Carcinoma.
Fang CY; Liew PL; Chen CL; Lin YH; Fang CL; Chen WY
Anticancer Res; 2017 Apr; 37(4):1891-1899. PubMed ID: 28373457
[TBL] [Abstract][Full Text] [Related]
43. A Five-mRNA Expression Signature to Predict Survival in Oral Squamous Cell Carcinoma by Integrated Bioinformatic Analyses.
Guo H; Li C; Su X; Huang X
Genet Test Mol Biomarkers; 2021 Aug; 25(8):517-527. PubMed ID: 34406843
[No Abstract] [Full Text] [Related]
44. CXCL12/CXCR4 pathway orchestrates CSC-like properties by CAF recruited tumor associated macrophage in OSCC.
Li X; Bu W; Meng L; Liu X; Wang S; Jiang L; Ren M; Fan Y; Sun H
Exp Cell Res; 2019 May; 378(2):131-138. PubMed ID: 30857971
[TBL] [Abstract][Full Text] [Related]
45. Elevated Serum Gas6 Is a Novel Prognostic Biomarker in Patients with Oral Squamous Cell Carcinoma.
Jiang T; Liu G; Wang L; Liu H
PLoS One; 2015; 10(7):e0133940. PubMed ID: 26207647
[TBL] [Abstract][Full Text] [Related]
46. CD163+ tumor-associated macrophages correlated with poor prognosis and cancer stem cells in oral squamous cell carcinoma.
He KF; Zhang L; Huang CF; Ma SR; Wang YF; Wang WM; Zhao ZL; Liu B; Zhao YF; Zhang WF; Sun ZJ
Biomed Res Int; 2014; 2014():838632. PubMed ID: 24883329
[TBL] [Abstract][Full Text] [Related]
47. CD206
Haque ASMR; Moriyama M; Kubota K; Ishiguro N; Sakamoto M; Chinju A; Mochizuki K; Sakamoto T; Kaneko N; Munemura R; Maehara T; Tanaka A; Hayashida JN; Kawano S; Kiyoshima T; Nakamura S
Sci Rep; 2019 Oct; 9(1):14611. PubMed ID: 31601953
[TBL] [Abstract][Full Text] [Related]
48. Microlocalization of CD68+ tumor-associated macrophages in tumor stroma correlated with poor clinical outcomes in oral squamous cell carcinoma patients.
Ni YH; Ding L; Huang XF; Dong YC; Hu QG; Hou YY
Tumour Biol; 2015 Jul; 36(7):5291-8. PubMed ID: 25666753
[TBL] [Abstract][Full Text] [Related]
49. Porphyromonas gingivalis initiates a mesenchymal-like transition through ZEB1 in gingival epithelial cells.
Sztukowska MN; Ojo A; Ahmed S; Carenbauer AL; Wang Q; Shumway B; Jenkinson HF; Wang H; Darling DS; Lamont RJ
Cell Microbiol; 2016 Jun; 18(6):844-58. PubMed ID: 26639759
[TBL] [Abstract][Full Text] [Related]
50. Persistent infection with Porphyromonas gingivalis increases the tumorigenic potential of human immortalised oral epithelial cells through ZFP36 inhibition.
Lu Z; Cao R; Geng F; Pan Y
Cell Prolif; 2024 Jun; 57(6):e13609. PubMed ID: 38351596
[TBL] [Abstract][Full Text] [Related]
51. Tissue mechanics and expression of TROP2 in oral squamous cell carcinoma with varying differentiation.
Zhang B; Gao S; Li R; Li Y; Cao R; Cheng J; Guo Y; Wang E; Huang Y; Zhang K
BMC Cancer; 2020 Aug; 20(1):815. PubMed ID: 32854652
[TBL] [Abstract][Full Text] [Related]
52. Serum miR-483-5p: a novel diagnostic and prognostic biomarker for patients with oral squamous cell carcinoma.
Xu H; Yang Y; Zhao H; Yang X; Luo Y; Ren Y; Liu W; Li N
Tumour Biol; 2016 Jan; 37(1):447-53. PubMed ID: 26224475
[TBL] [Abstract][Full Text] [Related]
53. Bax expression measured by AQUAnalysis is an independent prognostic marker in oral squamous cell carcinoma.
Bose P; Klimowicz AC; Kornaga E; Petrillo SK; Matthews TW; Chandarana S; Magliocco AM; Brockton NT; Dort JC
BMC Cancer; 2012 Aug; 12():332. PubMed ID: 22852863
[TBL] [Abstract][Full Text] [Related]
54. Role of hyaluronan mediated motility receptor gene in oral squamous cell carcinoma and clinical prognosis.
Tang Y; Xiao Y; Liao R
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2021 Dec; 46(12):1315-1324. PubMed ID: 35232899
[TBL] [Abstract][Full Text] [Related]
55. Expression of Kif5b protein is significantly associated with the progression, recurrence and prognosis of oral squamous cell carcinoma.
Luan YJ; Xu Y; Cai J; Dou Y; Yu WJ; Wang KT; Liu SH; Yang PS; Qu X; Wei FC
Eur Rev Med Pharmacol Sci; 2018 Jul; 22(14):4542-4550. PubMed ID: 30058692
[TBL] [Abstract][Full Text] [Related]
56. Dickkopf-related protein 1 as a biomarker of local immune status and worse prognosis of Oral squamous cell carcinoma.
Liu DX; Wu KH; Zang XY; Lu JY; Liu MY; Li CM; Gao L
Technol Health Care; 2024; 32(3):1473-1488. PubMed ID: 38073341
[TBL] [Abstract][Full Text] [Related]
57. Regulatory T cells and M2-polarized tumour-associated macrophages are associated with the oncogenesis and progression of oral squamous cell carcinoma.
Kouketsu A; Sato I; Oikawa M; Shimizu Y; Saito H; Tashiro K; Yamashita Y; Takahashi T; Kumamoto H
Int J Oral Maxillofac Surg; 2019 Oct; 48(10):1279-1288. PubMed ID: 31053518
[TBL] [Abstract][Full Text] [Related]
58. Porphyromonas gingivalis activates NFκB and MAPK pathways in human oral epithelial cells.
Groeger S; Jarzina F; Domann E; Meyle J
BMC Immunol; 2017 Jan; 18(1):1. PubMed ID: 28056810
[TBL] [Abstract][Full Text] [Related]
59. Contactin 1 (CNTN1) expression associates with regional lymph node metastasis and is a novel predictor of prognosis in patients with oral squamous cell carcinoma.
Wu HM; Cao W; Ye D; Ren GX; Wu YN; Guo W
Mol Med Rep; 2012 Aug; 6(2):265-70. PubMed ID: 22580838
[TBL] [Abstract][Full Text] [Related]
60. Persistent Exposure to
Geng F; Liu J; Guo Y; Li C; Wang H; Wang H; Zhao H; Pan Y
Front Cell Infect Microbiol; 2017; 7():57. PubMed ID: 28286742
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
